Mrs. Cho Cho Khine, MD Internal Medicine - Nephrology Medicare: Not Enrolled in Medicare Practice Location: 1415 Carlisle Dr, Inverness, IL 60010 Phone: 847-915-4426 |
News Archive
AstraZeneca today announced preliminary efficacy and safety data for AZD9291 in the first-line treatment of epidermal growth factor receptor mutation positive (EGFRm) advanced non-small cell lung cancer (NSCLC).
CASI Pharmaceuticals, Inc., a biopharmaceutical company dedicated to the acquisition, development and commercialization of innovative therapeutics addressing cancer and other unmet medical needs for the global market with a commercial focus on China, announced today that the China Food and Drug Administration (CFDA) has approved the Company's application to conduct a Phase 2 global clinical trial in ovarian clear cell carcinoma (OCCC) patients for its proprietary drug candidate ENMD-2076.
The University of Minnesota will present an international conference on the science behind One Health this spring in Minneapolis.
Insomnia's daytime impact appears to be greatest among those patients who have trouble both initiating and maintaining sleep, those with poor mental health, and those with childhood onset of the disorder, findings from the Great British Sleep Survey suggest.
Genetic mutations-sudden, random and usually harmful changes to the structure of a gene-are only one factor that determines the ultimate fate of a cell. Chicago scientists have discovered that a non-genetic molecular process also can play a role, and that experimenters can influence this process in bacteria, they report in the April 1 issue of the journal Nature.
› Verified 1 days ago